Track: Cardiovascular Endocrinology and Metabolism

The "Cardiovascular Endocrinology and Metabolism" session will delve into the critical link between metabolic disorders and cardiovascular diseases, highlighting how hormones and metabolic dysfunction contribute to heart health. It will explore the latest research on how conditions such as diabetes, obesity, and thyroid disorders affect cardiovascular function and increase the risk of heart disease. The session will focus on emerging treatments that target the intricate relationship between hormones, metabolism, and cardiovascular health, presenting new opportunities for prevention and more effective management. Through these insights, participants will gain a deeper understanding of how optimizing metabolic health can improve cardiovascular outcomes and enhance overall patient care.

Diabetes and Cardiovascular Health: Discuss the intricate relationship between diabetes and cardiovascular disease, focusing on how hyperglycemia accelerates atherosclerosis and other cardiovascular complications. Review strategies for optimizing glycemic control to reduce cardiovascular risk, and explore novel therapies targeting both metabolic and heart health.

Obesity and Its Impact on the Heart: Understand how obesity, often associated with metabolic syndrome, leads to cardiac dysfunction and increases the risk of heart failure, hypertension, and arrhythmias. Discuss the latest interventions in weight management, including pharmacological treatments, bariatric surgery, and lifestyle modifications, to reduce cardiovascular risk in obese patients.

Thyroid Disorders and Cardiovascular Risk: Explore the effects of thyroid dysfunction on cardiovascular health, including how hyperthyroidism and hypothyroidism can influence heart rate, blood pressure, and overall cardiovascular risk. Learn about the latest treatment approaches for thyroid disease and their impact on cardiovascular health outcomes.

Metabolic Syndrome and Cardiovascular Disease: Delve into the key components of metabolic syndrome—insulin resistance, hypertension, dyslipidemia, and central obesity—and their collective impact on cardiovascular disease. Discuss effective management strategies that target these metabolic abnormalities to reduce the risk of heart disease, stroke, and diabetes.

Adrenal Disorders and Cardiovascular Implications: Explore the relationship between adrenal disorders such as hyperaldosteronism, Cushing’s syndrome, and pheochromocytoma and cardiovascular disease. Discuss the diagnostic workup and treatment approaches for managing these disorders to minimize their cardiovascular impact.

Insulin Resistance and Atherosclerosis: Learn about the pathophysiological mechanisms behind insulin resistance and its role in the development of atherosclerosis. Discuss the importance of early detection and therapeutic interventions that target insulin resistance to reduce the risk of cardiovascular events in at-risk populations.

Dyslipidemia and Cardiovascular Disease: Gain in-depth knowledge of dyslipidemia and its crucial role in cardiovascular disease, including the contribution of high LDL cholesterol and low HDL cholesterol levels to the development of atherosclerosis. Learn about the latest lipid-lowering therapies such as statins, PCSK9 inhibitors, and lifestyle changes that can improve lipid profiles and reduce cardiovascular risk.

Emerging Therapies in Cardiovascular Endocrinology: Stay updated on the latest advancements in cardiovascular endocrinology, including new medications and therapies aimed at targeting metabolic and endocrine pathways to improve cardiovascular outcomes. Explore novel treatment options such as SGLT2 inhibitors and GLP-1 receptor agonists, and their dual benefits in managing both metabolic and cardiovascular health.

International Conference on Cardiology and Cardio Care

Track: Cardiovascular Endocrinology and Metabolism

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at